Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GRTX

Galera Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · GRTX

All alert types
17.15 USD 0.00 0.00%
As of Aug 3, 2026
16.00 Day range 17.15
0.01 52-week range 16.70
YTD
+77,854.55%
1 year
+59,037.93%
Open
16.00
Prev close
17.15
Mkt cap
3.56B
Vol
420
Avg vol
84.88K
EPS
0.64
P/E
0.06
Div yield
0.00%
More statistics
Low
16.00
High
17.15
Beta
2.60
Inst. own
0.00%
Dividend
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GRTX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-62.87 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 0.0×
FY 2017: -774×FY 2018: -9.8×FY 2019: -6.3×FY 2020: -3.4×FY 2021: -1.4×FY 2022: -0.6×FY 2023: -0.1×FY 2024: -0.1×FY 2025: 0.0×
FY 2017 5y median -0.1× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 0.3×
FY 2017: -240×FY 2018: -2.2×FY 2019: 4.7×FY 2020: 41.6×FY 2021: -2.0×FY 2022: -0.4×FY 2023: -0.0×FY 2024: -0.0×FY 2025: 0.3×
FY 2017 5y median -0.0× FY 2025
P/FCF -0.4×
FY 2017: -770×FY 2018: -10.3×FY 2019: -6.9×FY 2020: -4.2×FY 2021: -1.7×FY 2022: -0.9×FY 2023: -0.1×FY 2024: -0.2×FY 2025: -0.4×
FY 2017 5y median -0.4× FY 2025
EV/EBITDA 0.7×
FY 2017: -767×FY 2018: -9.2×FY 2019: -6.4×FY 2020: -3.5×FY 2021: -1.4×FY 2022: -0.7×FY 2023: 0.1×FY 2024: -7.2×FY 2025: 0.7×
FY 2017 5y median -0.7× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -279.1%
FY 2017: -0.1%FY 2018: -9.7%FY 2019: -14.5%FY 2020: -23.6%FY 2021: -57.6%FY 2022: -107.7%FY 2023: -693.3%FY 2024: -485.4%FY 2025: -279.1%
FY 2017 5y median -279.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE 2275.2%
FY 2017: 30.9%FY 2018: 22.6%FY 2019: -74.6%FY 2020: -1213.1%FY 2021: 138.8%FY 2022: 57.0%FY 2023: 45.0%FY 2024: 13.2%FY 2025: 2275.2%
FY 2017 5y median 57.0% FY 2025
ROIC -92.2%
FY 2017: -162.8%FY 2018: -29.4%FY 2019: -44.5%FY 2020: -100.2%FY 2021: -103.9%FY 2022: -166.7%FY 2023: -220.3%FY 2024: -236.5%FY 2025: -92.2%
FY 2017 5y median -166.7% FY 2025
ROA 2071.3%
FY 2017: -124.8%FY 2018: -26.9%FY 2019: -42.1%FY 2020: -88.3%FY 2021: -96.7%FY 2022: -141.3%FY 2023: -226.0%FY 2024: -187.7%FY 2025: 2071.3%
FY 2017 5y median -141.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 70.0%
FY 2017: 0.0%FY 2018: -0.7%FY 2019: -109.0%FY 2020: -39.2%FY 2021: -4.0%FY 2022: 30.2%FY 2023: 8.3%FY 2024: 57.1%FY 2025: 70.0%
FY 2017 FY 2025
EPS (diluted) 531.4%
FY 2017: 0.0%FY 2018: -7771.0%FY 2019: -71.3%FY 2020: -42.6%FY 2021: -14.1%FY 2022: 32.4%FY 2023: 42.2%FY 2024: 73.7%FY 2025: 531.4%
FY 2017 FY 2025
Free Cash Flow 50.2%
FY 2017: 0.0%FY 2018: 5.1%FY 2019: -110.1%FY 2020: -26.9%FY 2021: -13.7%FY 2022: 36.3%FY 2023: -3.4%FY 2024: 73.0%FY 2025: 50.2%
FY 2017 FY 2025

Financial Health

Current Ratio 11.0×
FY 2017: 3.5×FY 2018: 13.0×FY 2019: 12.1×FY 2020: 5.6×FY 2021: 6.0×FY 2022: 2.9×FY 2023: 4.4×FY 2024: 6.0×FY 2025: 11.0×
FY 2017 5y median 6.0× FY 2025
Quick Ratio 11.0×
FY 2017: 3.5×FY 2018: 13.0×FY 2019: 12.1×FY 2020: 5.6×FY 2021: 6.0×FY 2022: 2.9×FY 2023: 4.4×FY 2024: 6.0×FY 2025: 11.0×
FY 2017 5y median 6.0× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -1.1×FY 2025: 0.0×
FY 2017 5y median -0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2017: 0.3×FY 2018: 0.6×FY 2019: 0.4×FY 2020: 0.2×FY 2021: 0.3×FY 2022: 0.1×FY 2023: 0.2×FY 2024: -7.1×FY 2025: 1.1×
FY 2017 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: -110×FY 2019: -16.7×FY 2020: -14.5×FY 2021: -10.2×FY 2022: -4.4×FY 2023: -4.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median -4.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31